Thromboelastography Market

Global Thromboelastography Market Segment Analysis and Growth Driving Factors


Market Overview:
The global Thromboelastography Market is estimated to be valued at US$ 604.07 Mn in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Thromboelastography tests help monitor the entire coagulation process from clot initiation and formation to clot retraction and lysis. They help healthcare professionals guide transfusion strategies and coagulopathy management in conditions like surgery, trauma and obstetrical hemorrhage.

Market key trends:
Increasing adoption in trauma and cardiovascular surgeries is expected to be a key trend in the thromboelastography market over the forecast period. Thromboelastography provides real time information on clotting status which helps surgeons make rapid treatment decisions to correct any coagulopathy in complex surgeries and trauma cases. It enables goal directed therapy with blood products and reduces over transfusion compared to conventional tests.

Segment Analysis
The global thromboelastography market is segmented into product type and end user. By product type, theinstruments segment dominates the market and accounted for the largest market share in 2022. This is because thromboelastography instruments are the basic requirement for performing thromboelastography tests. Within instruments, analyzers segment holds the largest share due to increasing adoption of benchtop analyzers by hospitals and clinics.

By end user, the hospitals segment holds the largest share of the thromboelastography market. Increasing number of surgeries such as cardiac, orthopedic surgeries performed in hospitals drives the growth of this segment. Further, availability of reimbursement for thromboelastography tests in hospitals across developed countries promotes the adoption of thromboelastography technology.

Key Takeaways

– The Global Thromboelastography Market Size was valued at US$ 604.07 Mn in 2022 and is expected to reach US$ 1,038.83 Mn by 2030, expanding at a CAGR of 7.1% during the forecast period. The increasing prevalence of coagulation disorders and rising number of surgical procedures are some major factors driving the market.

– Regionally, North America dominated the global thromboelastography market in 2022 with a market share of around 35%, followed by Europe. This is attributed to the presence of advanced healthcare infrastructure and favorable reimbursement policies in the regions.

– Some of the leading players operating in the thromboelastography market are Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd. Key players are focusing on new product launches and geographical expansion strategies to gain higher market share.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it